1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.
Status:
Terminated
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
This is a phase II study that combines Trastuzumab with Pertuzumab to see how it works in
women age greater than 60 who have been diagnosed with HER2/neu overexpressed locally
advanced and/or metastatic breast carcinoma.